drugset / Trial / NCT00886574
Cilostazol Versus Aspirin for Primary Prevention of Atherosclerotic Events
Phase 4
Unknown
400 enrolled
Hanyang University
Ajou University School of Medicine · collabHallym University Medical Center · collabInha University Hospital · collabInje University · collabKorea University Guro Hospital · collabKyunghee University Medical Center · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
This multi-center, randomized controlled study aims to evaluate the efficacy of Cilostazol versus Aspirin for primary prevention of atherosclerotic events with Korean type 2 Diabetes Mellitus (DM) patients.
Timeline
- Start
- 2009-04
- Primary completion
- 2011-02
- Completion
- 2014-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aspirin | Small molecule | 100 mg | — |
| Comparator | Cilostazol | Small molecule | 200 mg | — |